Canton Strategic Holdings (CNTN) Other financing activities (2022 - 2026)
Canton Strategic Holdings (CNTN) reported Other financing activities of $3.6 million for Q1 2026, down 59.36% quarter-over-quarter from $8.8 million in Q4 2025.
Canton Strategic Holdings (CNTN) Other financing activities (2022 - 2026) Analysis & Trends
Canton Strategic Holdings has reported Other financing activities for 4 years, with the latest figure at $3.6 million in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to $3.6 million; the trailing twelve-month figure through Mar 2026 stood at $13.5 million (changed N/A YoY), and the FY2025 full-year result was $10.0 million, up 1408.44% from the prior year.
- Other financing activities for Q1 2026 stood at $3.6 million, down from $8.8 million in the prior quarter.
- The five-year high for Other financing activities was $8.8 million in Q4 2025, with the low at $138450.0 in Q3 2024.
- Historically, Other financing activities has averaged $2.4 million across 4 years, with a median of $737009.5 in 2022.
- The largest YoY upside for Other financing activities was 4191.95% in 2025 against a maximum downside of 588.14% in 2025.
- Canton Strategic Holdings' Other financing activities stood at $521294.0 in 2022, then sank by 60.86% to $204029.0 in 2024, then surged by 4191.95% to $8.8 million in 2025, then slumped by 59.36% to $3.6 million in 2026.
- The last three Other financing activities figures came in at $3.6 million (Q1 2026), $8.8 million (Q4 2025), and $952725.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.56 Mn |
| Mar 31, 2026 | 3.56 Mn |
| Dec 31, 2025 | 8.76 Mn |
| Dec 31, 2025 | 8.76 Mn |
| Sep 30, 2025 | 952,725.00 |
| Sep 30, 2025 | 952,725.00 |
| Dec 31, 2024 | 204,029.00 |
| Dec 31, 2024 | 204,029.00 |
| Sep 30, 2024 | 138,450.00 |
| Sep 30, 2024 | 138,450.00 |
| Mar 31, 2022 | 521,294.00 |
| Mar 31, 2022 | 521,294.00 |